Frequently Asked Questions

About Cultivate Confidence Counseling in Golden, CO

Ketamine-Assisted Psychotherapy, Psychedelic-Assisted Psychotherapy and Internal Family Systems Therapy Explained

About Myself

How long have you been a therapist?
What do you like about being a therapist?
Who is your ideal client?
What do you think makes therapy successful?

About My Practice

What are your specialties?
What modalities do you specialize in?
Do you offer an initial consultation, and how do I schedule an appointment?
Do you provide clinical supervision for pre-licensed therapists?

Psilocybin-Assisted Psychotherapy (PAP) FAQs

What is Psychedelic Assisted Psychotherapy?
How does PAP work?
Where will my PAP therapy session take place?
How does psychedelic therapy help?
What conditions does PAP help treat?
How quickly does psilocybin work?
Is Psychedelic-Assisted Psychotherapy (PAP) legal?
Is PAP safe?

Ketamine-Assisted Psychotherapy (KAP) FAQs

What is Ketamine-Assisted Psychotherapy
How does KAP work?
What conditions can KAP help treat?
How does ketamine work?
How quickly does ketamine work?
How do you combine Internal Family Systems (IFS) with Ketamine-Assisted Psychotherapy?
Is Ketamine-Assisted Psychotherapy legal?
Is KAP safe?

Want to learn more more about Psychedelic-Assisted Psychotherapy and Ketamine-Assisted Psychotherapy?

Below are some helpful research articles that dive in to these topics further.

Safety of Psychedelic-Assisted Psychotherapy (psilocybin)

  • Freitas, R. R., Gotsis, E. S., Gallo, A. T., Fitzgibbon, B. M., Bailey, N. W., & Fitzgerald, P. B. (2025). The safety of psilocybin-assisted psychotherapy: A systematic review. Australian & New Zealand Journal of Psychiatry — journal link. This is a strong, current, directly on-point citation: 24 studies reviewed, common adverse events were things like elevated blood pressure, headache, nausea, and transient anxiety; no deaths attributed to psilocybin; the review’s own conclusion is “cautious optimism” given the preliminary, heterogeneous nature of the data — a fair, honest characterization worth matching in your own copy.
  • A larger, newer adverse-event review for more depth: ScienceDirect systematic review, 42 studies/1,068 participants, concluding psilocybin “appears to have a favourable safety profile when administered in controlled settings.”

Ketamine-Assisted Psychotherapy research